Suchergebnisse - "anticancer agents"

PubPharm (113)

1

Novel zinc oxide nanoparticles of Teucrium polium suppress the malignant progression of gastric cancer cells through modulating apoptotic signaling pathways and epithelial to mesenchymal transition

enthalten in: Gene | 2023

von Bozgeyik, I. | Ege, M. | Temiz, E. | +5

2

In vitro evaluation of a prodrug approach for Gly-D-P18, a host defence peptide and novel anticancer agent

enthalten in: BMC Proceedings | 2015

von Hsu, A. | Devocelle, M. | Ward, J. | +1

3

In vitro evaluation of a prodrug approach for Gly-D-P18, a host defence peptide and novel anticancer agent

enthalten in: BMC proceedings | 2015

von Hsu, A. | Devocelle, M. | Ward, J. | +1

4

Synthesis and activity of conjugates Gallic acid - GnRH-III

enthalten in: BMC Proceedings | 2014

von Piccoli, J. | Cilli, E.

5

Synthesis and activity of conjugates Gallic acid - GnRH-III

enthalten in: BMC proceedings | 2014

von Piccoli, J. | Cilli, E.

6

Effects of specific nutrients on tax-dependent activation of NF-κB and MMP-9 in human T-cell lymphotropic virus -1 positive malignant T-lymphocytes

enthalten in: BMC genomics | 2014

von Harakeh, S. | Diab-Assaf, M. | Azar, R. | +12

7

Effects of specific nutrients on tax-dependent activation of NF-κB and MMP-9 in human T-cell lymphotropic virus -1 positive malignant T-lymphocytes

enthalten in: BMC genomics | 2014

von Harakeh, S. | Diab-Assaf, M. | Azar, R. | +12

8

Lower toxicity with targeted anticancer agents in phase I trials

enthalten in: Reactions weekly | 2012

9

Lower toxicity with targeted anticancer agents in phase I trials

enthalten in: Reactions weekly | 2012

10

Lower toxicity with targeted anticancer agents in phase I trials

enthalten in: Reactions weekly | 2012

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]